Atlas Trials

Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial

Clinical trial NCT00816114 · RECRUITING

Trial details

NCT number
NCT00816114
Sponsor
M.D. Anderson Cancer Center
Status
RECRUITING
Study type
OBSERVATIONAL
Chronic Myelogenous Leukemia
Start date
2005-06-08
Primary completion
2030-04-30
Enrollment
3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.